CYP2D6 GENOTYPING TO GUIDE USE OF TAMOXIFEN IN BREAST CANCER

被引：0
|
作者：
Irvin, William J., Jr. [1 ,2 ]
Weck, Karen E. [1 ,3 ,4 ]
Walko, Christine M. [1 ,2 ]
Ibrahim, Joseph G. [2 ]
Chiu, Wing. K. [2 ]
Dees, E. Claire [2 ]
Ogburn, Evan T. [5 ]
Desta, Zeruesenay [5 ]
Flockhart, David A. [5 ]
McLeod, Howard L. [1 ]
Evans, James P. [1 ,4 ]
Carey, Lisa A. [2 ]
机构：
[1] Univ N Carolina, Inst Pharmacogenom & Individualized Therapy, Chapel Hill, NC USA
[2] Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC USA
[3] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA
[4] Univ N Carolina, Dept Genet, Chapel Hill, NC USA
[5] Indiana Univ, Sch Med, Indianapolis, IN USA
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2011年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [1] CYP2D6 Genotyping and the Use of Tamoxifen in Breast Cancer
    Berry, Donald
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (17) : 1267 - 1269
  • [2] Re: CYP2D6 Genotyping and the Use of Tamoxifen in Breast Cancer
    Province, Michael A.
    Klein, Teri E.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (02)
  • [3] Re: CYP2D6 Genotyping and the Use of Tamoxifen in Breast Cancer Response
    Berry, Donald A.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (02)
  • [4] Clinical Implications of CYP2D6 Genotyping in Tamoxifen Treatment for Breast Cancer
    Dezentje, Vincent O.
    Guchelaar, Henk-Jan
    Nortier, Johan W. R.
    van de Velde, Cornelis J. H.
    Gelderblom, Hans
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (01) : 15 - 21
  • [5] Clinical implications of CYP2D6 genotyping on tamoxifen treatment in breast cancer
    Dezentje, V. O.
    Nortier, J. W. R.
    Guchelaar, H. J.
    van de Velde, C. J. H.
    Gelderblom, H.
    [J]. EJC SUPPLEMENTS, 2008, 6 (07): : 56 - 56
  • [6] Tamoxifen Use in Postmenopausal Breast Cancer: CYP2D6 Matters
    Brauch, Hiltrud
    Schroth, Werner
    Goetz, Matthew P.
    Muerdter, Thomas E.
    Winter, Stefan
    Ingle, James N.
    Schwab, Matthias
    Eichelbaum, Michel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (02) : 176 - 180
  • [7] CYP2D6 genotyping and tamoxifen in the treatment of post-menopausal breast cancer
    Damkier, Per
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (02) : 431 - 432
  • [8] Use of CYP2D6 genotyping in practice: tamoxifen dose adjustment
    Walko, Christine M.
    McLeod, Howard
    [J]. PHARMACOGENOMICS, 2012, 13 (06) : 691 - 697
  • [9] Use of the Roche Amplichip® for CYP2D6 Genotyping to Determine Tamoxifen Dose in a Multiracial Breast Cancer Population
    Weck, K. E.
    Irvin, W. J.
    Friedman, K.
    Anderson, S.
    Olajide, O.
    Dees, E. C.
    Peppercom, J.
    Chiu, M.
    Walko, C. M.
    Evans, J. P.
    McLeod, H. L.
    Carey, L. A.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 624 - 624
  • [10] The Impact of CYP2D6 Genotyping on Tamoxifen Treatment
    Ferraldeschi, Roberta
    Newman, William G.
    [J]. PHARMACEUTICALS, 2010, 3 (04) : 1122 - 1138
12345